Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Koru Medical Systems Inc
(NQ:
KRMD
)
2.140
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.140
Bid (Size)
2.040 (2)
Ask (Size)
3.400 (1)
Prev. Close
2.140
Today's Range
2.140 - 2.140
52wk Range
1.978 - 4.480
Shares Outstanding
45,710,500
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
April 17, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
April 11, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
Performance
YTD
-10.08%
-10.08%
1 Month
-2.73%
-2.73%
3 Month
+1.90%
+1.90%
6 Month
-11.93%
-11.93%
1 Year
-47.80%
-47.80%
More News
Read More
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
March 28, 2024
Via
InvestorPlace
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
March 18, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
Recap: KORU Medical Systems Q4 Earnings
March 13, 2024
Via
Benzinga
Earnings Outlook For KORU Medical Systems
March 12, 2024
Via
Benzinga
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
March 13, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
Earnings Scheduled For March 13, 2024
March 13, 2024
Via
Benzinga
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
March 11, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
March 06, 2024
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
February 21, 2024
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 29, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
November 28, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System
November 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
November 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
November 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
November 07, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
November 02, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
October 25, 2023
From
KORU Medical Systems
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 05, 2023
Via
Benzinga
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
October 05, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
October 04, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 15, 2023
From
KORU Medical Systems
Via
Business Wire
Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026
September 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
September 07, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.